Finally, we evaluated relative levels of these proteins in a Clinical Proteomic Tumor Analysis Consortium (CPTAC) cohort [9, 10]; NCOR2 is detected to a higher degree, and HSPG2 and SPTBN2 are detected to a lower degree in ovarian serous cystadenocarcinoma compared to normal tissue (no difference for KMT2C and MMP14) (Figure 1F). This evidence concerns the gene HSPG2 and ovarian serous cystadenocarcinoma.